PDC and Alzheimer disease: Mitochondrial dysfunction has also been documented in clinical and experimental AD studies [32] and, recently, decreased glucose oxidation in BACE1 over-expressing SH-SY5Y cells has been attributed to the impairment of tricarboxylic acid (TCA) cycle enzymes including the PDC [33].